NDC 41167-0360

Zantac 360

Famotidine

Zantac 360 is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Chattem, Inc.. The primary component is Famotidine.

Product ID41167-0360_11934068-b70b-4afe-aff8-82f2a79068b9
NDC41167-0360
Product TypeHuman Otc Drug
Proprietary NameZantac 360
Generic NameFamotidine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-04-12
Marketing CategoryANDA /
Application NumberANDA206531
Labeler NameChattem, Inc.
Substance NameFAMOTIDINE
Active Ingredient Strength10 mg/1
Pharm ClassesHistamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 41167-0360-2

1 BOTTLE in 1 CARTON (41167-0360-2) > 30 TABLET, FILM COATED in 1 BOTTLE
Marketing Start Date2021-04-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Zantac 360" or generic name "Famotidine"

NDCBrand NameGeneric Name
0363-0141Acid ControllerFamotidine
0363-0701Acid ControllerFamotidine
0363-1203acid controllerfamotidine
0113-7141basic care acid reducerFamotidine
0113-7194Basic Care famotidineFamotidine
0093-2748FamotidineFamotidine
0172-5728FamotidineFamotidine
0172-5729FamotidineFamotidine
0338-5197FamotidineFamotidine
0363-0036FamotidineFamotidine
0363-1899FamotidineFamotidine
0113-0141good sense acid reducerFamotidine
0113-0194Good Sense Acid ReducerFamotidine
0187-4420Pepcidfamotidine
0187-4440Pepcidfamotidine

Trademark Results [Zantac 360]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ZANTAC 360
ZANTAC 360
90179308 not registered Live/Pending
Chattem, Inc.
2020-09-14
ZANTAC 360
ZANTAC 360
90149088 not registered Live/Pending
Chattem, Inc.
2020-08-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.